Institute of Mother and Child, Warsaw, Poland
12
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Regorafenib in Patients With Refractory Primary Bone Tumors
Role: lead
COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus
Role: lead
High Five! - School-based Prevention of Overweight and Obesity Among 6 to 9 Year Olds
Role: lead
Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms
Role: lead
Cervical Occlusion Double-level Stitch Application
Role: collaborator
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Role: lead
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
Role: lead
Polish Infants and Toddler Nutritional Study
Role: collaborator
Three-dimensional Cleft Lip and Palate Morphology Prior to One-stage Cleft Repair
Role: collaborator
COmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR: COSMOS Study
Role: lead
Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy
Role: collaborator
The ADHERENCE Index - the Indicator of Effective Coping With the Requirements of the Disease of Children and Adolescents With Type 1 Diabetes
Role: lead
All 12 trials loaded